Maintenance and reliever therapy using inhaled corticosteroids and formoterol was associated with lower risk for asthma exacerbations, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
This strategy also reduced corticosteroid requirements, Chungsoo Kim, PharmD, a graduate student in the department of biomedical sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea, and colleagues wrote.
Current Global Initiative for Asthma guidelines recommend maintenance and reliever therapy (MART) comprising inhaled corticosteroids (ICS)